Bryan Johnson Plans to Sell or Shut Down Blueprint
What’s happening: Biotech entrepreneur and longevity advocate Bryan Johnson, known for his ambitious anti-aging initiatives, is reportedly considering selling or winding down his company, Blueprint, which focuses on health supplements and wellness products.
His reasoning: Johnson told Wired that he’s grown weary of managing the company, describing it as a “pain‑in‑the‑ass,” and stated, “I don’t need the money”. He feels the business side is undermining his credibility with his spiritual/philosophical message.
Project Blueprint: Launched in 2021, his flagship longevity project reportedly costs him around $2 million per year (~₹17 crore), and the company offers products like a ₹4,700 “longevity mix” and mushroom coffee priced at ₹3,600.
New religious venture clash: Earlier this year, Johnson launched a spiritual movement called “Don’t Die” via X, promoting endurance and transcendence. He believes running a commerce enterprise interferes with his philosophical messaging.
Financial posture: While a New York Times report claimed the company was losing about $1 million per month, Johnson maintains that it is currently breaking even, with both profitable and loss‑making months.
Bottom line
Bryan Johnson, currently in his late 40s, is stepping away from his high-cost anti-aging business. His decision stems from a desire to prioritize his philosophical mission and avoid the credibility conflict posed by a commercial enterprise. Despite media reports about its financial struggles, Johnson asserts that Blueprint is stable but simply no longer aligns with his personal goals.